Clinical trials
Phase 3 Craniocerebral Trauma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nantes University Hospital | 2 |
| University of Washington | 2 |
| Nanjing Yoko Biomedical Co., Ltd. | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Ottawa Hospital Research Institute | 1 |
| POLYSAN Scientific & Technological Pharmaceutical Company | 1 |
| Universidad Austral de Chile | 1 |
| University Hospital, Angers | 1 |
| University of Miami | 1 |
| VA Office of Research and Development | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Craniocerebral Trauma | 12 |
| Brain Injuries, Traumatic | 5 |
| Brain Concussion | 2 |
| Brain Injuries | 2 |
| Cognitive Dysfunction | 2 |
| Adrenal Insufficiency | 1 |
| Anosmia | 1 |
| Epilepsy, Post-Traumatic | 1 |
| Head Injuries, Closed | 1 |
| Hemorrhage | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.